Manufacturing

Articles

Launched in 2018, the Poseidon network works to bring together pharmaceutical providers to reform the pharmaceutical logistics process.

Zuellig, Hellman, and Modum Join Poseidon’s Pharma Ocean Freight Network

An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.

Bovine Heparin Meets Acceptable Impurity Levels

The company has said that all three of its operating sites in China started back up on Feb. 12 and that it is closely monitoring the outbreak.

WuXi Biologics Provides Update on Operations in Light of Coronavirus Outbreak

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Researching excipient grades and sources, as well as screening suppliers and materials, form the basis of programs to mitigate risk.

The Search for Transparency in Excipient Sourcing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Vein-to-vein programs are focusing on data access and traceability. 

Managing Risk for Cell and Gene Therapy Logistics

GE Healthcare Life Sciences’ new facility for cell and gene processing supplies will be open in 2022. 

GE Builds Single-Use Kit Manufacturing Facility in Switzerland

Aiming to break the bottlenecks that are slowing commercialization of innovative therapies, a new $50-million center in Boston will develop both cell and viral vector products within a single facility.


New Center Marks Aggressive Push into CGMP Manufacturing of Cell and Gene Therapies

Gary Dailey is vice-president, Global Marketing, Electronic Materials, at Avantor.

Claudia BerrÃ³n is senior vice-president, Strategy and Commercial Operations, Biopharma Production at Avantor.

Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.

Applying Lessons Learned from the Semiconductor Industry

Communications and planning are crucial to recovering from supply, operations, and facility disruptions. 

Mitigating Risk to Secure the Drug Supply Chain

The collaboration aims to reduce “vein-to-vein” time for patients and to optimize manufacturing and supply operations.